Miltenyi Biomedicine GmbH
General Information
Identification Code: 145659542963-95
Website: [object Object]
Entity Form: GmbH
Registration Category: Companies & groups
Registration Date: 6/2/2021
Last Update: 1/29/2024
EP Accredited Number: 0
Mission & Interests
Goals: Miltenyi Biomedicine is a biopharmaceutical company whose mission is to bring accessible and innovative cell and gene therapies to patients suffering from serious diseases like cancer, Alzheimer’s disease, Parkinson’s disease, and diabetes. Committed to providing patients worldwide with cutting-edge therapies to fight life-threatening diseases, we are implementing a variety of technology platforms to find the best therapeutic match and to further improve the safety and efficacy of current therapies. Outstanding examples of Miltenyi’ s expertise in the therapeutic arena are immunotherapy approaches currently under study in international trials for solid tumors and hematological malignancies (for more information explore our pipeline).
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Competition
- Public health
- Research and innovation
Levels of Interest:
- global
- european
- sub-national
- national
Activities
Main EU Legislative Proposals: Revision of the EU general pharmaceutical & orphan legislations, ATMP policy, research policy, Horizon Europe, Europe’s Beating Cancer Plan, SoHo legislation, EU HTA
Communication Activities: N/A
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: Friedrich-Ebert-Strasse 68
Post Code: 51429
City: Bergisch Gladbach
Country: GERMANY
Phone: [object Object]
EU Office
Address: Friedrich-Ebert-Strasse 68
Post Code: 51429
City: Bergisch Gladbach
Country: GERMANY
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: The estimate is based on 50% of the salary of the Miltenyi Biomedicine employee falling under the scope of the Register, based on the proportion of employee's time spent on these activities, 100% of consultancy costs and of our trade association membership fees
Membership Information
Members10 Percent: 0
Members25 Percent: 0
Members50 Percent: 1
Members75 Percent: 0
Members: 1
Members F T E: 0.5
Info Members: Miltenyi Biomedicine employs 1 colleague full-time engaged in Brussels, and spending ca. 50% of his time on activities covered by the EU register.
Structure
Structure Type: Structure
Is Member Of: TRANSFORM Alliance (European Alliance for Transformative Therapies): https://www.eucope.org/transform-multi-stakeholder-approach-to-gene-and-cell-therapies/
Organisation Members: Eucope, the European Confederation of Pharmaceutical Entrepreneurs